NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

BSGM

Biosig Technologies Inc

Jul 11 • 04:00PM ET

5.23

Dollar change -0.63
Percentage change -10.75	%

Healthcare • Medical Devices • USA • NASD

Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.62	Insider Own	39.71%	Shs Outstand	24.25M	Perf Week	-49.76%
Market Cap	161.05M	Forward P/E	-	EPS next Y	-0.17	Insider Trans	0.00%	Shs Float	18.57M	Perf Month	-21.71%
Enterprise Value	157.51M	PEG	-	EPS next Q	-0.04	Inst Own	27.68%	Short Float	7.27%	Perf Quarter	730.16%
Income	-9.79M	P/S	5368.33	EPS this Y	66.67%	Inst Trans	7.91%	Short Ratio	1.35	Perf Half Y	283.15%
Sales	0.03M	P/B	48.68	EPS next Y	32.00%	ROA	-324.29%	Short Interest	1.35M	Perf YTD	251.01%
Book/sh	0.11	P/C	43.18	EPS next 5Y	-	ROE	-8041.70%	52W High	14.11 -62.93%	Perf Year	1265.54%
Cash/sh	0.12	P/FCF	-	EPS past 3/5Y	57.17% 46.11%	ROIC	-361.25%	52W Low	0.23 2173.91%	Perf 3Y	-23.81%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-55.07% -	Gross Margin	-403.85%	Volatility	44.56% 22.37%	Perf 5Y	-92.82%
Dividend TTM	-	EV/Sales	5250.33	EPS Y/Y TTM	80.60%	Oper. Margin	-47726.92%	ATR (14)	1.68	Perf 10Y	-91.10%
Dividend Ex-Date	-	Quick Ratio	2.37	Sales Y/Y TTM	-3.70%	Profit Margin	-37653.85%	RSI (14)	42.14	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.37	EPS Q/Q	62.27%	SMA20	-31.27%	Beta	1.69	Target Price	10.00
Payout	-	Debt/Eq	0.02	Sales Q/Q	-100.00%	SMA50	-3.17%	Rel Volume	1.77	Prev Close	5.86
Employees	5	LT Debt/Eq	0.00	Earnings	May 19	SMA200	149.11%	Avg Volume	1.00M	Price	5.23
IPO	Oct 30, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-180.00% -	Trades		Volume	1,771,642	Change	-10.75%

Jul-11-25 09:00AM	BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor (Business Wire) -10.75%
Jul-08-25 12:29PM	BioSig, Streamex to Raise $1.1B for Gold Tokenization Initiative on Solana (CoinDesk) -27.36%
Jul-07-25 06:41PM	BioSig Technologies, Inc. and Streamex Exchange Corporation Announce Definitive Agreements for up to $1.1B USD in Growth Financing to Launch Gold Backed Treasury Management Strategy and to Rapidly Expand RWA Tokenization for the Commodities Markets (Business Wire) +10.95%
Jun-09-25 10:30AM	BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors (GlobeNewswire) -14.05%
Jun-04-25 08:25AM	BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor (GlobeNewswire) -10.59%
06:45PM	Loading…
May-28-25 06:45PM	CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO) (GlobeNewswire) -8.74% -13.68%
01:46PM	BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (GlobeNewswire)
01:07PM	Streamex and BioSig Announce the Successful Closing of Share Exchange Transaction and Executive Leadership Changes Bringing a First-Mover Real World Asset Tokenization Company to the Nasdaq (GlobeNewswire)
May-27-25 08:20AM	BioSig Technologies signs definitive share exchange agreement with Streamex (TipRanks) +21.40%
May-26-25 12:42PM	BioSig Stock Surges Following Share Exchange Deal With Streamex (Zacks)
May-25-25 06:31PM	BioSig Technologies, Inc. (BSGM) Turns to Tokenization with Streamex Acquisition (Insider Monkey)
May-23-25 07:56PM	BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain. (GlobeNewswire) +24.24% +21.40%
May-05-25 09:42AM	BioSig Enters into an LOI to Merge with Streamex Exchange Corp. (GlobeNewswire) +5.84%
08:30AM	BioSig Enters into an LOI to Merge with Streamex Exchange Corp. Creating a Publicly Listed Real-World Asset Tokenization Company Led by Seasoned Industry Executives (GlobeNewswire)
Apr-24-25 12:00PM	Biosig Technologies (BSGM) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) +31.25%
09:00AM	Loading…
Mar-26-25 09:00AM	BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market (GlobeNewswire) +11.36%
Jan-22-25 07:00AM	OTC Markets Group Announces Quarterly Index Performance and Rebalancing (GlobeNewswire)
Nov-13-24 03:14PM	BioSig Regains Compliance with Nasdaq's Minimum Bid Price Requirement (GlobeNewswire) -11.62%
Oct-22-24 03:13PM	BioSig Technologies Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel (GlobeNewswire) +34.03%
Aug-01-24 04:32AM	BioSig intends to acquire Neuro-Kinesis assets (Medical Device Network)
Jul-31-24 09:45AM	BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation (GlobeNewswire)
Jul-25-24 01:57PM	BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024 (GlobeNewswire) -9.95%

BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Los Angeles, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BSGM

Biosig Technologies Inc

Upgrade your FINVIZ experience